Create Free Account

By creating account you will get access to hot stocks & personalised emails

Polynovo Ltd

Healthcare AU PNV

2.01AUD
-0.11(5.19%)

Last update at 2024-12-19T05:11:00Z

Day Range

1.982.07
LowHigh

52 Week Range

1.482.78
LowHigh

Fundamentals

  • Previous Close 2.12
  • Market Cap1423.14M
  • Volume2517143
  • P/E Ratio206.00
  • Dividend Yield-%
  • EBITDA2.64M
  • Revenue TTM103.23M
  • Revenue Per Share TTM0.15
  • Gross Profit TTM 53.80M
  • Diluted EPS TTM0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -4.93310M -1.15092M -4.55040M -4.12710M -3.18989M
Minority interest - - - - -
Net income -4.92454M -1.19253M -4.60503M -4.19374M -1.81597M
Selling general administrative 50.84M 28.58M 24.05M 19.57M 11.87M
Selling and marketing expenses 2.36M 1.26M 0.80M 0.80M 0.83M
Gross profit 60.81M 39.24M 27.60M 20.45M 12.06M
Reconciled depreciation 2.04M 1.59M 0.92M 0.84M 0.31M
Ebit -4.74698M 0.54M -4.32777M -4.10910M -4.56381M
Ebitda -2.70952M 2.13M -3.40709M -3.27192M -4.25421M
Depreciation and amortization 2.04M 1.59M 0.92M 0.84M 0.31M
Non operating income net other - - - - -
Operating income -5.08856M 0.54M -4.23010M -4.04543M -4.56381M
Other operating expenses 47.03M 26.83M 23.16M 18.13M 17.91M
Interest expense 0.19M 0.32M 0.22M 0.02M 0.02M
Tax provision -0.00856M 0.04M 0.05M 0.07M 0.00000M
Interest income 0.87M 0.00067M 0.00110M 0.06M 0.35M
Net interest income 0.16M -0.31470M -0.32030M 0.02M 0.33M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.00856M 0.04M 0.05M 0.07M -1.37392M
Total revenue 65.24M 41.44M 29.16M 22.16M 13.35M
Total operating expenses 66.99M 39.49M 30.75M 24.59M 16.62M
Cost of revenue 4.43M 2.20M 1.56M 1.70M 1.29M
Total other income expense net 1.10M -0.57957M -1.08261M 0.09M 1.37M
Discontinued operations - - - - -
Net income from continuing ops -4.92454M -1.19253M -4.60503M -4.19374M -3.18989M
Net income applicable to common shares -4.92454M -1.19253M -4.60503M -4.19374M -3.18989M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 109.17M 92.62M 34.97M 38.34M 37.86M
Intangible assets 0.91M 1.16M 1.40M 1.65M 1.90M
Earning assets - - - - -
Other current assets 3.30M 0.31M 0.15M 0.15M 0.78M
Total liab 37.04M 27.24M 17.26M 15.99M 14.04M
Total stockholder equity 72.12M 65.38M 17.72M 22.35M 23.81M
Deferred long term liab - 0.18M 0.33M 0.48M -
Other current liab 14.11M 9.93M 5.93M 6.84M 7.86M
Common stock 191.60M 191.59M 139.43M 139.25M 139.07M
Capital stock 191.60M 191.59M 139.43M 139.25M 139.07M
Retained earnings -116.11700M -121.37831M -116.45377M -115.26124M -110.65621M
Other liab - 0.42M 0.29M 0.22M 0.17M
Good will - - - - -
Other assets - 0.74M 0.63M 0.62M 0.14M
Cash 45.91M 46.85M 6.10M 7.69M 11.65M
Cash and equivalents - - - - -
Total current liabilities 23.25M 12.67M 7.76M 8.65M 9.47M
Current deferred revenue 0.21M -1.89014M -1.83418M -2.87537M -5.62825M
Net debt -30.52700M -30.80326M 4.89M 2.31M -1.61590M
Short term debt 2.54M 1.89M 1.79M 2.88M 5.63M
Short long term debt 1.89M 1.40M 1.33M 2.53M 5.30M
Short long term debt total 15.38M 16.04M 10.99M 10.00M 10.03M
Other stockholder equity - -70.21300M -22.97673M -23.98926M -28.41429M
Property plant equipment - 23.37M 16.75M 19.82M 16.54M
Total current assets 79.30M 67.35M 16.19M 16.24M 19.28M
Long term investments 0.57M 0.56M 0.30M 0.14M 0.14M
Net tangible assets - 64.23M 16.31M 20.70M 21.91M
Short term investments 0.05M 0.05M 0.05M 0.05M 0.05M
Net receivables 21.07M 13.69M 6.09M 5.67M 3.14M
Long term debt 0.74M 1.79M 2.80M 5.06M 1.98M
Inventory 8.97M 4.53M 2.54M 1.96M 1.22M
Accounts payable 6.39M 2.74M 1.87M 1.81M 1.61M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3.36000M -4.82986M -5.26164M -1.63722M -4.60227M
Additional paid in capital - - - - -
Common stock total equity - - - - 139.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.04M 0.18M 0.33M 0.48M -18.43707M
Deferred long term asset charges - - - - -
Non current assets total 29.87M 25.27M 18.78M 22.10M 18.58M
Capital lease obligations 12.75M 12.86M 6.86M 2.41M 2.74M
Long term debt total - 14.15M 9.21M 7.12M 4.40M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.84877M 5.86M -3.56723M -8.84446M 19.00M
Change to liabilities 4.17M -0.14233M 1.79M 1.03M 1.57M
Total cashflows from investing activities -0.84877M 5.86M -3.56723M -8.84446M 13.06M
Net borrowings -3.98661M -5.56831M -0.25037M 7.03M 7.03M
Total cash from financing activities 48.06M -5.38831M -0.07037M 7.03M 0.95M
Change to operating activities 0.10M 0.80M 0.48M 0.57M -0.79989M
Net income -4.92454M -1.19253M -4.60503M -4.19374M -3.18989M
Change in cash 40.74M -1.58636M -3.95915M -2.27299M 10.77M
Begin period cash flow 6.10M 7.69M 11.65M 13.92M 3.15M
End period cash flow 46.85M 6.10M 7.69M 11.65M 13.92M
Total cash from operating activities -6.61253M -2.05703M -0.25022M -0.42732M -3.36973M
Issuance of capital stock 52.05M 0.18M 0.18M - 0.95M
Depreciation 2.28M 1.80M 1.12M 0.84M 0.31M
Other cashflows from investing activities 0.68M 0.00040M 0.00148M 0.02M 0.58M
Dividends paid - - - - -
Change to inventory -1.99499M -0.57546M -0.74279M -0.00159M -0.13186M
Change to account receivables -7.42715M -0.27607M -2.36737M -0.87052M -1.00764M
Sale purchase of stock 52.05M 0.18M 0.18M 0.00000M 0.95M
Other cashflows from financing activities -0.82676M 1.53M 6.89M 7.03M 13.06M
Change to netincome 1.18M -2.32075M 3.46M 2.20M -0.49905M
Capital expenditures 1.53M 0.49M 3.57M 8.87M 6.52M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -9.42215M -0.85153M -3.11017M -0.87212M 0.79M
Stock based compensation 1.11M -3.47958M 2.63M 2.06M -
Other non cash items -3.97054M -2.66199M 3.24M 2.93M 2.88M
Free cash flow -8.14076M -2.54896M -3.81894M -9.29654M -9.88994M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PNV
Polynovo Ltd		 -0.11 5.19% 2.01 206.00 138.89 13.79 20.21 13.83 352.63
COH
Cochlear Ltd		 -3.32 1.13% 291.11 53.50 45.87 8.50 10.43 8.47 32.70
AVH
Avita Therapeutics Inc		 -0.2 5.13% 3.70 - - 9.07 28.09 5.79 -10.0538
EBR
Ebr Systems Inc CDR		 0.12 14.53% 0.98 - - - 6.51 - -3.6785
IMR
Imricor Medical Systems Inc		 -0.02 2.05% 0.95 - - 313.01 3.97 231.39 -2.6027

Reports Covered

Stock Research & News

View All

Profile

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Polynovo Ltd

320 Lorimer Street, Port Melbourne, VIC, Australia, 3207

Key Executives

Name Title Year Born
Mr. Jan-Marcel Gielen C.A. CFO & Company Sec. NA
Dr. David McQuillan Ph.D. Chief Technical & Scientific Officer NA
Mr. Swami Raote BPHARM, M.B.A. CEO & Director NA
Mr. Ahmed Hassan Director of Operations NA
Ms. Teena Chadha APAC Marketing & Distributor Mang. NA
Ms. Monica Benyk HR Mang. NA
Dr. Tim Moore Principal Scientist NA
Mr. Edward Graubart Sr. VP of Sales & Marketing (Americas) NA
Mr. Jan-Marcel Gielen C.A. CFO & Company Secretary NA
Mr. Philip Scorgie Chief Information Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.